Zhejiang Nhu Co Ltd Market Cap ($11.51 Billion)
Market Cap & Net Worth: Zhejiang Nhu Co Ltd (002001)
Zhejiang Nhu Co Ltd market cap. Zhejiang Nhu Co Ltd (SHE:002001) has a market capitalization of $11.51 Billion (CN¥78.68 Billion) as of November 1, 2026. Listed on the SHE stock exchange, this China-based company holds position #1940 globally and #169 in its home market, demonstrating a 2.40% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Nhu Co Ltd's stock price CN¥25.60 by its total outstanding shares 3073421680 (3.07 Billion). Also see 002001 cash flow conversion for how efficiently the company converts equity into cash flow.
Zhejiang Nhu Co Ltd Market Cap History (2015–2026)
Zhejiang Nhu Co Ltd market cap history from 2015 to 2026. Data shows growth from $2.57 Billion to $11.51 Billion (16.11% CAGR). Check Zhejiang Nhu Co Ltd (002001) stock price for real-time trading data and today's change.
Index Memberships
Zhejiang Nhu Co Ltd is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Shanghai Shenzhen CSI 300
CSI300
|
$4.01 Trillion | 0.29% | #69 of 285 |
Weight: Zhejiang Nhu Co Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Zhejiang Nhu Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Nhu Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 002001 year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.51x
Zhejiang Nhu Co Ltd's market cap is 0.51 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.67x
Zhejiang Nhu Co Ltd's market cap is 1.67 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.91 Billion | $4.70 Billion | $1.20 Billion | 0.62x | 2.42x |
| 2017 | $5.85 Billion | $6.24 Billion | $1.70 Billion | 0.94x | 3.43x |
| 2018 | $4.00 Billion | $8.68 Billion | $3.08 Billion | 0.46x | 1.30x |
| 2019 | $6.41 Billion | $7.66 Billion | $2.17 Billion | 0.84x | 2.96x |
| 2020 | $9.46 Billion | $10.31 Billion | $3.56 Billion | 0.92x | 2.65x |
| 2021 | $10.67 Billion | $14.92 Billion | $4.36 Billion | 0.72x | 2.45x |
| 2022 | $7.98 Billion | $15.93 Billion | $3.62 Billion | 0.50x | 2.20x |
| 2023 | $7.45 Billion | $15.12 Billion | $2.70 Billion | 0.49x | 2.75x |
| 2024 | $9.88 Billion | $21.61 Billion | $5.87 Billion | 0.46x | 1.68x |
| 2025 | $11.33 Billion | $22.25 Billion | $6.76 Billion | 0.51x | 1.67x |
Competitor Companies of 002001 by Market Capitalization
Companies near Zhejiang Nhu Co Ltd in the global market cap rankings as of November 1, 2026. Also see Zhejiang Nhu Co Ltd asset portfolio for a full breakdown of the balance sheet.
Key companies related to Zhejiang Nhu Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Zhejiang Nhu Co Ltd (2015–2026)
Market capitalization of Zhejiang Nhu Co Ltd from 2015 to today. Between 2015 and today, Zhejiang Nhu Co Ltd's market cap moved from $2.57 Billion to $ 11.51 Billion, with a yearly change of 16.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥11.51 Billion | +1.63% |
| 2025 | CN¥11.33 Billion | +14.66% |
| 2024 | CN¥9.88 Billion | +32.63% |
| 2023 | CN¥7.45 Billion | -6.65% |
| 2022 | CN¥7.98 Billion | -25.21% |
| 2021 | CN¥10.67 Billion | +12.85% |
| 2020 | CN¥9.46 Billion | +47.46% |
| 2019 | CN¥6.41 Billion | +60.43% |
| 2018 | CN¥4.00 Billion | -31.63% |
| 2017 | CN¥5.85 Billion | +100.61% |
| 2016 | CN¥2.91 Billion | +13.46% |
| 2015 | CN¥2.57 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Zhejiang Nhu Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.51 Billion USD |
| MoneyControl | $11.51 Billion USD |
| MarketWatch | $11.51 Billion USD |
| marketcap.company | $11.51 Billion USD |
| Reuters | $11.51 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zhejiang Nhu Co Ltd
Zhejiang NHU Company Ltd., together with its subsidiaries, produces and sells nutritional products, fragrances and flavors, polymer materials, and active pharmaceutical ingredients in China and internationally. It operates through Pharmaceutical and Chemical; and Other segments. The company offers animal nutrition products comprising vitamins, amino acids, and carotenoids for poultry, swine, rumi… Read more